XBIOTECH INC's ticker is XBIT and the CUSIP is 98400H102. A total of 45 filers reported holding XBIOTECH INC in Q1 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $101,000 | +36.5% | 13,348 | -4.1% | 0.01% | +100.0% |
Q1 2018 | $74,000 | -25.3% | 13,915 | -45.0% | 0.00% | -25.0% |
Q4 2017 | $99,000 | -44.4% | 25,293 | -38.0% | 0.00% | -55.6% |
Q3 2017 | $178,000 | -24.6% | 40,826 | -18.8% | 0.01% | -30.8% |
Q2 2017 | $236,000 | +129.1% | 50,306 | +392.9% | 0.01% | +116.7% |
Q4 2016 | $103,000 | – | 10,206 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtus ETF Advisers LLC | 15,584 | $244,000 | 0.10% |
Thomasville National Bank | 13,650 | $218,000 | 0.03% |
CAAS CAPITAL MANAGEMENT LP | 138,316 | $2,165,000 | 0.02% |
WINTON GROUP Ltd | 13,219 | $207,000 | 0.02% |
Vestcor Inc | 19,371 | $303,000 | 0.01% |
Belvedere Trading LLC | 14,600 | $228,000 | 0.01% |
ALPS ADVISORS INC | 52,398 | $820,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 14,232 | $227,000 | 0.01% |
Belvedere Trading LLC | 6,983 | $109,000 | 0.00% |
SYNOVUS FINANCIAL CORP | 11,796 | $185,000 | 0.00% |